PUBLIC CONTRACT · 2016
AQ100966 aquisição de medicamentos inovadores para tratamento hepatite 2016
- Contract value
- €184,735.32
- Signed on
- 4 August 2016
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 2378747PUBLISHED SUBJECT
AQ100966 AQUISIÇÃO DE MEDICAMENTOS INOVADORES PARA TRATAMENTO HEPATITE 2016
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES, LDA · Tax ID 503604704
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €184,735.32
- Procedure base price
- €184,735.32
- Total effective price
- Not reported on Portal BASE
- Publication date
- 30 August 2016
- Award date
- 4 August 2016
- Signing date
- 4 August 2016
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2286819
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.